SARS-CoV-2 Isn’t Going Away, Experts Predict

As politicians try to schedule an end to the pandemic, scientists say the virus will stick around as an endemic disease similar to the common cold.

Written byDavid Adam
| 4 min read
endemic endemicity covid-19 sars2 sars-cov-2 coronavirus pandemic vaccine

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: © ISTOCK.COM, JORDANSIMEONOV

Never one to use two words when six will do, the British Prime Minister Boris Johnson has reached for a range of verbal contortions to predict an end to the COVID-19 pandemic.

He’s used the 1815 battle of Waterloo—“the morale-boosting bugle-blasting excitement of Wellington’s Prussian allies coming through the woods”—to describe vaccinations, and warned against the premature lifting of restrictions by invoking Steve McQueen’s fate in the 1960s movie The Great Escape: “if we try to jump the fence now, we will simply tangle ourselves in the last barbed wire.”

Despite the verbose promises of victory as vaccine programs around the world accelerate, the pandemic is unlikely to end with the knock-out blow against the virus that Johnson and other political leaders promise. The best we can hope for, scientists predict, is an uneasy truce.

I don’t think that anyone who is reasonably well-informed about infectious ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies